Stem cell therapy for white matter disorders: don't forget the microenvironment!

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• White matter disorders (WMDs) cause significant disability and mortality.
• WMDs affect glial cells (astrocytes, oligodendrocytes) and myelin, leading to neurological dysfunction.
• Current understanding of WMDs is limited by studies in rodent models, potentially overlooking human-specific factors.

Purpose of the Study:

• To highlight the potential of cell replacement therapy for WMDs.
• To emphasize the importance of multimodal therapeutic strategies.
• To underscore the critical role of the microenvironment in white matter repair.

Main Methods:

• Review of preclinical studies and early clinical trials in WMDs.
• Analysis of cell types involved in white matter repair.
• Consideration of microenvironmental factors influencing therapeutic outcomes.

Main Results:

• Preclinical studies show promise for glial progenitor cell transplantation for remyelination.
• WMDs affect multiple cell types beyond oligodendrocytes, requiring broader therapeutic targets.
• Human glial cells exhibit greater regenerative capacity than mouse cells, suggesting limitations in rodent models.

Conclusions:

• Cell replacement therapy is a promising avenue for WMDs.
• Multimodal approaches combining cell transplantation and microenvironment modulation are essential.
• Further research is needed to understand and optimize the microenvironment for effective white matter repair in humans.